By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Policy & Systems > Quality & Safety > NAFDAC Warns Nigerian Consumers After South African Antacid Recall Due to Contamination Risk
Quality & Safety

NAFDAC Warns Nigerian Consumers After South African Antacid Recall Due to Contamination Risk

GMJ
Last updated: 25/05/2026 17:53
By
GMJ Policy Desk
Share
5 Min Read
NAFDAC logo with pharmaceutical safety warning symbols and South African flag
NAFDAC issues urgent public alert after South African authorities recall Citro-Soda Regular antacid batches due to contamination risk at Johannesburg manufacturing facility. Nigerian consumers advised to exercise caution with affected product. — Photo: Engin Akyurt / Pexels
SHARE
🎧 Listen to this article4:15 min · 610 words · GMJ Audio

Updated 25/05/2026

Contents
  • Manufacturing facility contamination prompts immediate recall
  • Nigerian regulatory response and consumer guidance
    • Key takeaways
  • Frequently asked questions
    • What should Nigerian consumers do if they have Citro-Soda Regular?
    • Is Citro-Soda Regular commonly available in Nigeria?
    • How does NAFDAC monitor international drug recalls?
2 min read|423 words

Nigeria’s drug regulatory authority has issued an urgent public alert following the recall of specific batches of Citro-Soda Regular antacid in South Africa due to potential contamination at the manufacturing facility. The National Agency for Food and Drug Administration and Control (NAFDAC) was notified by the South African Health Products Regulatory Authority (SAPHRA) of contamination risks identified at the Adcock Ingram Clayville facility in Johannesburg.

Multiple batches
of Citro-Soda Regular recalled across South Africa following contamination risk at manufacturing facility

Manufacturing facility contamination prompts immediate recall

The recall affects specific batches of Citro-Soda Regular, an effervescent urinary alkalinizer and gastric antacid commonly used for treating heartburn and indigestion. According to SAPHRA, the contamination risk was identified at the Adcock Ingram Clayville manufacturing plant in Johannesburg.

NAFDAC’s alert, designated as Public Alert No. 025/2026, advises Nigerian consumers and healthcare providers to exercise caution regarding the affected product. The agency emphasizes that while the recall is currently limited to South Africa, Nigerian consumers who may have purchased the product during travel or through import channels should be aware of the safety concerns.

Submit Your Paper
GMJ_Submit_Banner

Nigerian regulatory response and consumer guidance

NAFDAC has enhanced border screening procedures for pharmaceutical products originating from the affected South African facility. Consumer safety remains the primary concern as regulatory authorities coordinate their response across the region.

🎙️ Related Podcast Episodes
🎧 #13 | Six Years After COVID-19: Is the World Better Prepared for the Next Pandemic? · 19m
🎧 #3 Global Nestlé Infant Formula Recall: The Power of Modern Public Health in Practice | GMJ Official Podcast · 21m

Multiple batches of Citro-Soda Regular have been recalled in South Africa due to contamination risks identified at the Adcock Ingram manufacturing facility

— NAFDAC Public Alert No. 025/2026, National Agency for Food and Drug Administration and Control (2026)

Key takeaways

  • NAFDAC issued urgent alert following South African recall of Citro-Soda Regular batches
  • Contamination risk identified at Adcock Ingram Clayville manufacturing facility in Johannesburg
  • Nigerian consumers advised to exercise caution with the affected antacid product
  • Enhanced surveillance and border screening implemented for pharmaceutical imports

Frequently asked questions

What should Nigerian consumers do if they have Citro-Soda Regular?

Consumers should check batch numbers against the recalled list and discontinue use immediately if affected. Contact NAFDAC or your healthcare provider for guidance on safe disposal and alternative treatments.

Is Citro-Soda Regular commonly available in Nigeria?

While not widely distributed through official channels in Nigeria, some consumers may have obtained the product during travel to South Africa or through informal import networks.

How does NAFDAC monitor international drug recalls?

NAFDAC maintains active communication with international regulatory authorities like SAPHRA to protect Nigerian consumers.

The coordinated response between NAFDAC and South African authorities demonstrates the importance of international regulatory cooperation in protecting consumer safety.

Source: Public Alert No. 025/2026 -Alert on the Recall Specific Batches of Antacid (Citro-Soda regular) in South Africa

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

FDA Issues Safety Alert for Boston Scientific Accolade Pacemakers Over Premature Battery DepletionJul 4, 2026
Colorado hospitals reduce stigma in pregnancy substance use care through evidence-based training programJul 3, 2026
UK Health Security Agency Publishes New Hantavirus Transmission Parameters for Public Health ResponseJun 29, 2026
FDA Issues Early Alert for Baxter Volara Breathing Device Air LeaksJun 27, 2026
PG
Written by
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →  ·  ORCID 0000-0001-7609-4515
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
Get the GMJ News digest
Evidence-based health journalism in your inbox. No spam; unsubscribe anytime.
TAGGED:antacid recalldrug contaminationNAFDACpharmaceutical safetySouth Africa
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByGMJ Policy Desk
Follow:
GMJ Policy Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Acting NIAID Chief Steps Down as Lab Safety Concerns Mount

Dr. Jeffery Taubenberger has resigned as acting NIAID director after 13 months,…

Autism Spectrum Disorder and Comorbid Schizophrenia: Clinical Practice Guidelines

New clinical practice guidelines address the complex challenges of diagnosing and treating…

AI Workflow Identifies Folic Acid as Potential Treatment for Diabetic Wound Healing

NUS researchers used AI to identify folic acid as a promising treatment…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Medical device safety alert showing heart pump controller with warning symbol
Policy & SystemsQuality & Safety

FDA Issues Early Alert for Heart Pump Controller Software Error That May Cause Dangerous Restarts

By
GMJ Policy Desk
25/05/2026
Medical ventilator breathing circuit equipment in hospital intensive care unitIllustrative image · Photo by Marlon Castor on Pexels (Pexels License)
Policy & SystemsQuality & Safety

FDA Issues Early Alert for Hamilton Medical Ventilator Circuit Obstruction Risk

By
GMJ Policy Desk
26/06/2026
Healthcare professionals and diverse patients illustrating language barrier challenges in medical settingsIllustrative image · Photo by Stéf -b. on Pexels (Pexels License)
Policy & SystemsQuality & Safety

Language Barriers in Healthcare: How Communication Gaps Affect Patient Safety and Quality of Care

By
GMJ Policy Desk
19/06/2026
FDA Class I recall notice for VOCSN V+Pro ventilators showing medical device safety alert
Policy & SystemsQuality & Safety

FDA Issues Class I Recall for VOCSN V+Pro Ventilators Over Critical Oxygen Leak Risk

By
GMJ Policy Desk
24/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up